| scholarly article | Q13442814 |
| P50 | author | Annemieke C Heijboer | Q41125724 |
| Hanno Pijl | Q59211762 | ||
| P2093 | author name string | L M Havekes | |
| J A Romijn | |||
| H Pijl | |||
| E P M Corssmit | |||
| A M van den Hoek | |||
| P J Voshol | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| A frameshift mutation in MC4R associated with dominantly inherited human obesity | Q28117916 | ||
| A frameshift mutation in human MC4R is associated with a dominant form of obesity | Q28285286 | ||
| Role of melanocortinergic neurons in feeding and the agouti obesity syndrome | Q28300979 | ||
| Central melanocortin receptors regulate insulin action | Q28360753 | ||
| Central nervous system control of food intake | Q29547439 | ||
| New insights into sympathetic regulation of glucose and fat metabolism | Q33905747 | ||
| Role of melanocortins in control of obesity | Q34377037 | ||
| Neuropeptides, food intake and body weight regulation: a hypothalamic focus | Q35048780 | ||
| Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes | Q36889306 | ||
| AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor | Q40833844 | ||
| The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. | Q42435903 | ||
| In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake | Q43778803 | ||
| Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity | Q43972527 | ||
| Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats | Q44028436 | ||
| Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. | Q44566038 | ||
| Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice | Q44631805 | ||
| PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet | Q44995518 | ||
| Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin | Q45077923 | ||
| Is the energy homeostasis system inherently biased toward weight gain? | Q47173540 | ||
| The central melanocortin system can directly regulate serum insulin levels | Q47620409 | ||
| Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system | Q47772359 | ||
| Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic | Q48292251 | ||
| Truncal vagotomy does not affect postabsorptive glucose metabolism in humans. | Q51587612 | ||
| Sex differences in the adaptation of glucose metabolism to short-term fasting: effects of oral contraceptives. | Q51592470 | ||
| Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. | Q52540034 | ||
| Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome | Q71721641 | ||
| The NPY/AgRP neuron and energy homeostasis | Q77628422 | ||
| P433 | issue | 8 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 1621-1626 | |
| P577 | publication date | 2005-06-22 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice | |
| P478 | volume | 48 |
| Q37771277 | Alpha-melanocyte stimulating hormone: production and degradation |
| Q35152229 | Circulating insulin stimulates fatty acid retention in white adipose tissue via KATP channel activation in the central nervous system only in insulin-sensitive mice |
| Q34615377 | Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice |
| Q37429162 | Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues |
| Q46950221 | Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice |
| Q36640460 | Gut-brain axis: regulation of glucose metabolism |
| Q37808731 | Hypothalamic control of energy metabolism via the autonomic nervous system. |
| Q40212153 | Intermittent MTII application evokes repeated anorexia and robust fat and weight loss |
| Q36543067 | Investigational therapies in the treatment of obesity |
| Q33602487 | Leptin revisited: its mechanism of action and potential for treating diabetes |
| Q37314990 | Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. |
| Q43210742 | Monitoring FoxO1 localization in chemically identified neurons |
| Q28301492 | Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity |
| Q104134945 | Optogenetic stimulation of the liver-projecting melanocortinergic pathway promotes hepatic glucose production |
| Q34076219 | Pro-opiomelanocortin gene transfer to the nucleus of the solitary track but not arcuate nucleus ameliorates chronic diet-induced obesity |
| Q35442056 | RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals |
| Q36138183 | Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways |
| Q35561118 | Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice |
| Q36054459 | The MC4 receptor and control of appetite |
| Q34517720 | The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity |
| Q36003378 | The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. |
| Q51475312 | Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet. |
Search more.